Editas Medicine, Inc.
EDIT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25,117 | -$53,235 | -$76,088 | -$45,395 |
| Dep. & Amort. | $721 | $1,577 | $1,917 | $1,381 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,228 | $2,664 | $2,979 | $4,020 |
| Change in WC | -$11,012 | -$4,620 | $17,615 | -$12,099 |
| Other Non-Cash | $2,337 | $3,402 | $5,778 | $1,331 |
| Operating Cash Flow | -$30,843 | -$50,212 | -$47,799 | -$50,762 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$433 | $151 | -$114 | -$540 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $4 |
| Inv. Sales/Matur. | $40,006 | $42,499 | $56,501 | $31,494 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $39,573 | $42,650 | $56,387 | $30,958 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$2,872 | $0 | $0 |
| Stock Issued | $17,148 | $7,184 | $1,435 | $55,513 |
| Stock Repurch. | $0 | $228 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $21 | $2,872 | -$2,872 | $0 |
| Financing Cash Flow | $17,169 | $7,412 | -$1,437 | $55,513 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $25,899 | -$150 | $7,151 | $35,709 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $142,419 | $142,569 | $135,418 | $99,709 |
| End Cash | $168,318 | $142,419 | $142,569 | $135,418 |
| Free Cash Flow | -$31,276 | -$50,212 | -$47,913 | -$51,302 |